FAT10: Function and Relationship with Cancer

(E-pub Ahead of Print)

Author(s): Senfeng Xiang, Xuejing Shao, Ji Cao, Bo Yang, Qiaojun He, Meidan Ying*.

Journal Name: Current Molecular Pharmacology

Become EABM
Become Reviewer


Posttranslational protein modifications are known to be extensively involved in the cancer process, and a growing number of studies have revealed that the ubiquitin-like modifier FAT10 is directly involved in cancer development. FAT10 was found to be highly upregulated in various cancer types, such as glioma, hepatocellular carcinoma, breast cancer and gastrointestinal cancer. Protein FAT10ylation and interactions with FAT10 lead to the functional change of proteins, including proteasomal degradation, subcellular delocalization and stabilization, eventually having significant effects on cancer cell proliferation, invasion, metastasis and even tumorigenesis. In this review, we summarize the current knowledge on FAT10 and discuss its biological functions in the cancer process, as well as potential therapy strategies based on the FAT10 pathway.

Keywords: FAT10, FAT10ylation, cancer, substrate, ubiquitin-like, post-translational modificatioFAT10, post-translational modification

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1874467212666191113130312
Price: $95

Article Metrics

PDF: 3